Mr. Speaker, I thank my hon. colleague for his question.
I can assure him that we have enormous respect for Canada's researchers and scientists. I believe I have even visited his lab.
Let me set the record straight. We made historic investments in biomanufacturing in Canada. Examples include Medicago in Quebec City, VBI Vaccines Inc. in Ontario, Precision NanoSystems in Vancouver, ImmunoVaccine Technologies in Nova Scotia, Entos Pharmaceuticals in Alberta, Providence Therapeutics in Alberta, Symvivo in British Columbia, Biodextris in Laval and Glycovax Pharma in Montreal.
We will continue to invest—